675551 event 1721667500 1721670128
Michael H. Ronzetti
Graduate Student
Early Translation Branch
Division of Preclinical Innovation
National Center for Advancing Translational Sciences
National Institutes of Health

REGISTER HERE for Zoom link

Lyme disease remains a significant public health concern with over half a million cases reported annually that results in an economic burden of nearly $3 billion. Current treatments fail to completely clear the infection in nearly 15% of cases and lose effectiveness as the disease progresses, highlighting the need for new and more potent therapeutics. By employing parallel approaches—phenotypic screening of live Borrelia burgdorferi sensu lato, the causative agent of Lyme disease, and target-based drug design focusing on a known protease—we have identified several promising candidates with potential applications for eradicating the bacteria in vivo.

]]> "Advancing Lyme Disease Therapeutics Through A Multimodal Screening Approach" - Michael H. Ronzetti , University of Maryland, National Institutes of Health

]]> Lauren James - lauren.james@emory.edu

]]> 655285 1292 1254 1795 187423 188880 189814